Mesenchymal stem cells in the treatment of severe COVID-19.

Authors

Santosh Kesari, Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USAFollow
Gregory C Kasper
Lev Verkh
Terese C Hammond, Providence Saint John's Health Center, Santa Monica, USAFollow
Marla L Matal
Jay W Hammerling
Nikolai Tankovich
Adrianus P Lim
Kevin H Zhao
Tiffany Juarez, Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USAFollow
Roberta E Redfern
Jaya M Gill, Pacific Neuroscience Institute, Santa Monica, USAFollow
Natsuko Nomura, Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USAFollow
Audrey Hiemer, Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USAFollow
Annie Heng, Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USAFollow
Jessica Shoemaker

Document Type

Article

Publication Date

1-1-2021

Publication Title

Transl Med Commun

Keywords

california; santa monica; jwci; sjci; covid-19

Clinical Institute

Cancer

Specialty

Oncology

Specialty

Infectious Diseases

Recommended Citation

Kesari, Santosh; Kasper, Gregory C; Verkh, Lev; Hammond, Terese C; Matal, Marla L; Hammerling, Jay W; Tankovich, Nikolai; Lim, Adrianus P; Zhao, Kevin H; Juarez, Tiffany; Redfern, Roberta E; Gill, Jaya M; Nomura, Natsuko; Hiemer, Audrey; Heng, Annie; and Shoemaker, Jessica, "Mesenchymal stem cells in the treatment of severe COVID-19." (2021). Articles, Abstracts, and Reports. 5194.
https://digitalcommons.providence.org/publications/5194